The European Commission (EC) has approved trazimera (trastuzumab), Pfizer’s biosimilar to Roche’s Herceptin, making it Pfizer’s first oncology biosimilar to...
Read More...
The post Pfizer unveils its first oncology biosimilar in Europe appeared first on Pharmaceutical Technology.
Original Article: Pfizer unveils its first oncology biosimilar in Europe